Science Explorer Back to mapMap
Discussion
Researcher · Nova Medical (United States) · United States

Zakera Shums

Zakera Shums publishes mostly in Hepatology, Rheumatology and Genetics, on topics such as Liver Diseases and Immunity, Systemic Lupus Erythematosus Research and Inflammatory Bowel Disease.

OpenAlex
World rank
#876,968
of 7,710,434 ranked researchers
Rank in United States
#289,993
of 1,627,098
Works
78
Citations
2.9k
Citations per work
37.3
h-index
32
i10-index 48Top 13% in Hepatology
Zakera Shums

What does Zakera Shums research?

Zakera Shums's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (8%).

Health Sciences: 43 works · 54.8% of their workMedicine: 43 works · 54.8% of their workHepatology: 17 works · 22.1% of their workRheumatology: 14 works · 18.1% of their workSurgery: 6 works · 7.5% of their workEpidemiology: 6 works · 7.1% of their workEverything else: 21 works · 26.6% of their workLife Sciences: 15 works · 18.6% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 10.2% of their workGenetics: 8 works · 10.2% of their workImmunology and Microbiology: 7 works · 8.4% of their workImmunology: 7 works · 8.4% of their workTHEIR WORKZakera Shums78works
Life Sciences19%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4354.8%
  2. Everything else2126.6%
    1. Biochemistry, Genetics and Molecular Biology810.2%
    2. Immunology and Microbiology78.4%
  1. 1Hepatology22% of their works
  2. 2Rheumatology18% of their works
  3. 3Genetics10% of their works
  4. 4Immunology8% of their works
  5. 5Surgery8% of their works
  6. 6Epidemiology7% of their works

Research topics

Which keywords describe Zakera Shums's research?

The keywords of their largest research topics: Epidemiology, Pathogenesis, Diagnosis, Management, Autoimmune Hepatitis, Primary Biliary Cirrhosis, Antiphospholipid Syndrome and Systemic Lupus Erythematosus.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Epidemiology472 topics
  2. Pathogenesis472 topics
  3. Diagnosis432 topics
  4. Management432 topics
  5. Autoimmune Hepatitis311 topic
  6. Primary Biliary Cirrhosis311 topic
  7. Antiphospholipid Syndrome251 topic
  8. Systemic Lupus Erythematosus251 topic
  9. Crohn's Disease161 topic
  10. Inflammatory Bowel Disease161 topic
  11. Celiac Disease121 topic
  12. Gluten Sensitivity121 topic
  13. Platelets121 topic
  14. Thrombosis121 topic
  15. Hepatic Encephalopathy101 topic
  16. Liver Cirrhosis101 topic
  17. Genetic Mutations81 topic
  18. NAFLD81 topic
  19. NASH81 topic
  20. Primary Immunodeficiency81 topic

Where does Zakera Shums work?

Zakera Shums's main affiliation in the publication record is Nova Medical (United States), United States.

How many publications and citations does Zakera Shums have?

OpenAlex counts 78 works and 2,907 citations for Zakera Shums, an h-index of 32, ranking #876,968 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Zakera Shums. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.